Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Characterization of HMGB1/2 Interactome in Prostate Cancer by Yeast Two Hybrid Approach: Potential Pathobiological Implications.

Barreiro-Alonso A, Cámara-Quílez M, Salamini-Montemurri M, Lamas-Maceiras M, Vizoso-Vázquez Á, Rodríguez-Belmonte E, Quindós-Varela M, Martínez-Iglesias O, Figueroa A, Cerdán ME.

Cancers (Basel). 2019 Nov 5;11(11). pii: E1729. doi: 10.3390/cancers11111729.

2.

Differential characteristics of HMGB2 versus HMGB1 and their perspectives in ovary and prostate cancer.

Cámara-Quílez M, Barreiro-Alonso A, Rodríguez-Bemonte E, Quindós-Varela M, Cerdán E, Lamas-Maceiras M.

Curr Med Chem. 2019 Jan 23. doi: 10.2174/0929867326666190123120338. [Epub ahead of print]

PMID:
30674244
3.

Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.

Barreiro-Alonso A, Lamas-Maceiras M, García-Díaz R, Rodríguez-Belmonte E, Yu L, Pardo M, Choudhary JS, Cerdán ME.

Oncotarget. 2018 Apr 10;9(27):19050-19064. doi: 10.18632/oncotarget.24887. eCollection 2018 Apr 10.

4.

The HMGB protein Ixr1 interacts with Ssn8 and Tdh3 involved in transcriptional regulation.

Barreiro-Alonso A, Lamas-Maceiras M, Cerdán EM, Vizoso-Vázquez Á.

FEMS Yeast Res. 2018 Mar 1;18(2). doi: 10.1093/femsyr/foy013.

PMID:
29438513
5.

High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer.

Barreiro-Alonso A, Lamas-Maceiras M, Rodríguez-Belmonte E, Vizoso-Vázquez Á, Quindós M, Cerdán ME.

Oxid Med Cell Longev. 2016;2016:5845061. doi: 10.1155/2016/5845061. Epub 2015 Nov 23. Review.

Supplemental Content

Loading ...
Support Center